ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS

Identifying physical and behavioral factors and mechanisms to improve detection and phenotyping of vocal hyperfunction

Active
Institution
Massachusetts General Hospital, MA
Principal investigator
Robert E Hillman
Funding
$820K
Duration
2017–2028
Open portfolio

Moonbase score

Still being scored

Abstract

Project Summary/Abstract Voice disorders have been estimated to affect approximately 30% of the adult population in the United States at some point in their lives with the most prevalent being associated with vocal hyperfunction. Phonotraumatic vocal hyperfunction (PVH) is associated with the formation of benign vocal fold lesions (e.g., nodules and polyps). Vocal hyperfunction is also associated with dysphonia that occurs in the absence of concurrent vocal fold trauma or other structural/neurological abnormalities (e.g., muscle tension dysphonia), which is referred to as non- phonotraumatic vocal hyperfunction (NPVH). Unfortunately, the prevention, diagnosis, and treatment of these hyperfunctional voice disorders continue to be hampered by limited knowledge of the etiological and pathophysiological mechanisms that underlie specific voice disorders within the broad range of those associated with vocal hyperfunction. This project continues to elucidate multiple factors/mechanisms that are assumed to play important roles in causing and maintaining hyperfunctional voice disorders using a combination of data from ambulatory voice monitoring and other important sources: reflux status, personality, vocal reactivity to environmental sound levels, responses to voice therapy and ambulatory biofeedback, assessment of auditory-motor deficits, and model- generated estimates of phonatory physiological parameters that are difficult/impossible to measure clinically. Research during this second grant cycle will focus on the interrelated goals of further improving the detection of PVH and NPVH and identifying clinically meaningful subgroups (phenotypes) within these two broad categories. Detection will be improved by developing two new ambulatory measures, energy dissipation dose (EDD), which is expected to be more sensitive to mild (early-stage) phonotrauma, and a time series voicing-resting ratio (VRR) that will provide objective insight into how the relationship between vocal load and recovery is associated with phonotrauma and vocal fatigue. A combination of advanced statistical and machine learning approaches will be applied to our growing comprehensive/multidimensional voice database to optimize the discovery of PVH and NPVH subgroups based on differences in objective measures of daily (ambulatory) vocal behavior and phonatory pathophysiology. The subgroups will be further differentiated by additional measures that reflect deeper insights into pathophysiological mechanisms (e.g., intrinsic laryngeal muscle activation levels, vocal fold collision pressure, etc.) and potential predisposing factors (e.g., personality, reflux, etc.). Achieving the goals of this research program will lead to improved prevention, differential diagnosis, and more focused and efficient treatment of these highly prevalent voice disorders.

LOADING MOONBASE SCORE

NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSP50ZDC1-SRB-Ypersonalityvoiceambulatorysubgroupsvocal foldvocalfoldpathophysiological mechanisms

Questions for Massachusetts General Hospital

Answered by the team behind this research.

Same researchers, same institution, same topic, scored first.